| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.16 | 0.003 |
| mRNA | piperlongumine:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.11 | 0.004 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | -0.089 | 0.005 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.16 | 0.008 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.15 | 0.008 |
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.01 |